Overview

Mepolizumab for Eosinophilic Fasciitis

Status:
Not yet recruiting
Trial end date:
2023-12-15
Target enrollment:
Participant gender:
Summary
This is a proof of concept pilot study to investigate the efficacy of mepolizumab in the treatment of eosinophilic fasciitis.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
GlaxoSmithKline